A method for establishing allocation equity among patients with and without hepatocellular carcinoma on a common liver transplant waiting list-Reference-Cited by-同舟云学术

A method for establishing allocation equity among patients with and without hepatocellular carcinoma on a common liver transplant waiting list

Published:2014-02 Issue:2 Volume:60 Page:290-297
ISSN:0168-8278
Container-title:Journal of Hepatology
language:en
Short-container-title:Journal of Hepatology

Author:

Vitale Alessandro,Volk Michael L.,De Feo Tullia Maria,Burra Patrizia,Frigo Anna Chiara,Ramirez Morales Rafael,De Carlis Luciano,Belli Luca,Colledan Michele,Fagiuoli Stefano,Rossi Giorgio,Andorno Enzo,Baccarani Umberto,Regalia Enrico,Vivarelli Marco,Donataccio Matteo,Cillo Umberto

Publisher

Elsevier BV

Subject

Hepatology

Reference20 articles.

1. Are patients with Child’s a cirrhosis and hepatocellular carcinoma appropriate candidates for liver transplantation?;Berry;Am J Transplant,2012

2. Liver match, a prospective observational cohort study on liver transplantation in Italy: study design and current practice of donor-recipient matching;Angelico;Dig Liver Dis,2011

3. Survival benefit-based deceased-donor liver allocation;Schaubel;Am J Transplant,2009

4. Model for end-stage liver disease (MELD) and allocation of donor livers;Wiesner;Gastroenterology,2003

5. Waiting list removal rates among patients with chronic and malignant liver diseases;Freeman;Am J Transplant,2006

Cited by 82 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Waiting list mortality and 5-year transplant survival benefit of patients with MASLD: An Italian liver transplant registry study;JHEP Reports;2024-09

2. Fairness and pitfalls of the Italian waiting list for elective liver transplantation: The ECALITA registry study;Digestive and Liver Disease;2024-09

3. Dynamic Exception Points for Fair Liver Allocation;Service Science;2024-06-10

4. Liver and Kidney Transplantation in Elderly Patients;Transplantology;2024-05-31

5. Multidisciplinary Treatment of Hepatocellular Carcinoma in 2023: Italian practice Treatment Guidelines of the Italian Association for the Study of the Liver (AISF), Italian Association of Medical Oncology (AIOM), Italian Association of Hepato-Bilio-Pancreatic Surgery (AICEP), Italian Association of Hospital Gastroenterologists (AIGO), Italian Association of Radiology and Clinical Oncology (AIRO), Italian Society of Pathological Anatomy and Diagnostic Cytology (SIAPeC-IAP), Italian Society of Surgery (SIC), Italian Society of Gastroenterology (SIGE), Italian Society of Medical and Interventional Radiology (SIRM), Italian Organ Transplant Society (SITO), and Association of Patients with Hepatitis and Liver Disease (EpaC) – Part I – Surgical treatments;Digestive and Liver Disease;2024-02